Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Remember GvHD?

<< Previous

Bullboard Posts

Next >>

Comment by TheKneeHon Sep 03, 2021 4:05pm

103 Views

Post# 33810649

RE:RE:RE:RE:Remember GvHD?

Pretty sure Kaly were the only ones who had a license to use the Talent IP. This other company is not using the same technology.

The only point I was trynig to make is that there is demand for GvHD (Kaly said that repeatedly in the past).

Anyway, Claritas is just doing the same scheme now -- same stick, different carrot. If people look at the split history of Claritas, all past RS (including Kaly) are there. Combine that with the constant Claritas + Salzman Group dealings, it's not hard to see where this will eventually go.

But hey, if people end up making money with Claritas, cool.

Chritters wrote: Yes correct but Kaly said they were the only ones with a Licence for GVHD!! Obviously like everything else you here its BS

TheKneeH wrote: It is back to Talent. This article doesn't refer to Kaly/Claritas.

This other company made a GvHD related announcement, and the stock went up around 25% ealier today. When Kaly/Claritas announced they were getting rid of their GvHD program, I seem to recal them mentionning something like "it wasn't worth pursuing..."

just saying

Chritters wrote: I thought it was being sold back to Talent!! Probably never had it in the first place,

TheKneeH wrote: For those who oroginally were on Kaly and the GvHD bandwagon

https://ca.finance.yahoo.com/news/cellect-biotechnology-announces-apograft-bone-202000784.html